JPWO2023008404A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2023008404A5 JPWO2023008404A5 JP2023538536A JP2023538536A JPWO2023008404A5 JP WO2023008404 A5 JPWO2023008404 A5 JP WO2023008404A5 JP 2023538536 A JP2023538536 A JP 2023538536A JP 2023538536 A JP2023538536 A JP 2023538536A JP WO2023008404 A5 JPWO2023008404 A5 JP WO2023008404A5
- Authority
- JP
- Japan
- Prior art keywords
- humanized antibody
- reagent
- specific
- measured
- suppressing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021121812 | 2021-07-26 | ||
| PCT/JP2022/028698 WO2023008404A1 (ja) | 2021-07-26 | 2022-07-26 | ヒト化抗体を含む試薬 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2023008404A1 JPWO2023008404A1 (https=) | 2023-02-02 |
| JPWO2023008404A5 true JPWO2023008404A5 (https=) | 2024-04-17 |
Family
ID=85086990
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023538536A Pending JPWO2023008404A1 (https=) | 2021-07-26 | 2022-07-26 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250102496A1 (https=) |
| EP (1) | EP4372009A4 (https=) |
| JP (1) | JPWO2023008404A1 (https=) |
| KR (1) | KR20240005839A (https=) |
| CN (1) | CN117716037A (https=) |
| TW (1) | TW202311743A (https=) |
| WO (1) | WO2023008404A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025135074A1 (ja) * | 2023-12-18 | 2025-06-26 | デンカ株式会社 | 標的抗原の測定方法並びにそれに用いる抗体、不溶性粒子及び標的抗原測定用キット |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07260786A (ja) * | 1994-03-18 | 1995-10-13 | Tosoh Corp | ヒト由来一定領域を有する抗体を使用する免疫測定方法 |
| WO2005058359A2 (en) * | 2003-12-15 | 2005-06-30 | Theralogic Gmbh & Co. Kg | Method for neutralizing effects of crp for increasing immune reactions to hiv |
| ES2595638T3 (es) * | 2007-09-26 | 2017-01-02 | Chugai Seiyaku Kabushiki Kaisha | Método para modificar el punto isoeléctrico de un anticuerpo mediante la sustitución de aminoácidos en una CDR |
| EP2050764A1 (en) * | 2007-10-15 | 2009-04-22 | sanofi-aventis | Novel polyvalent bispecific antibody format and uses thereof |
| JP4657328B2 (ja) | 2008-07-18 | 2011-03-23 | 栄研化学株式会社 | 免疫反応干渉物質の除去方法 |
| KR20110112307A (ko) * | 2008-11-25 | 2011-10-12 | 앨더 바이오파마슈티컬즈, 인코포레이티드 | 알부민을 상승시키고 및／또는 ｃｒｐ를 낮추는 ｉｌ６의 길항제 |
| ES2871648T7 (es) | 2014-09-17 | 2024-10-16 | Univ Cornell | Identificación del estado de la fertilidad masculina mediante la determinación de la capacitación del esperma |
| CA3013522A1 (en) * | 2016-02-05 | 2017-08-10 | Dana Genetic A/S | Method for diagnosing and treating cancer using antibodies that bind to c1 inactivator, c reactive protein and/or complement component c4 |
-
2022
- 2022-07-26 TW TW111127964A patent/TW202311743A/zh unknown
- 2022-07-26 JP JP2023538536A patent/JPWO2023008404A1/ja active Pending
- 2022-07-26 KR KR1020237041539A patent/KR20240005839A/ko active Pending
- 2022-07-26 US US18/290,904 patent/US20250102496A1/en active Pending
- 2022-07-26 EP EP22849465.4A patent/EP4372009A4/en active Pending
- 2022-07-26 CN CN202280052194.2A patent/CN117716037A/zh active Pending
- 2022-07-26 WO PCT/JP2022/028698 patent/WO2023008404A1/ja not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2016203292B2 (en) | Monoclonal antibody, and immunoassay using same | |
| Vashist et al. | Immunoassays: an overview | |
| JP2002040024A (ja) | Ｃ反応性蛋白についての免疫測定 | |
| JP2007525427A5 (https=) | ||
| JP2677753B2 (ja) | 凝集イムノアッセイ法 | |
| JP2019015737A5 (https=) | ||
| JPWO2023008404A5 (https=) | ||
| JP2022033935A5 (https=) | ||
| CN110716050A (zh) | 抗原组合在制备用于肺癌相关自身抗体检测的试剂盒中的用途以及相应的试剂盒和检测方法 | |
| Oaks et al. | Xenoreactive antibodies and latent fibrin formation in VAD and cardiac transplant recipients can confound the detection and measurement of anti-AT1R antibodies | |
| GB2025045A (en) | Hepatitis b testing reagent and method | |
| JP7315966B2 (ja) | 生物学的試料中の遊離ａｉｍの免疫学的分析方法 | |
| CN113728233B (zh) | 用于生物样品中的游离aim的免疫分析方法和分析试剂盒 | |
| TW202424490A (zh) | 免疫學測定方法、非特異反應抑制方法、免疫學測定試劑、免疫學測定試劑套組、組成物、非特異反應抑制劑、及用途 | |
| CN112352161B (zh) | 用于检测由免疫测定试剂的不完全分散引起的异常结果的方法 | |
| US20230094382A1 (en) | Methods and devices for determining a level of a complement activation product | |
| US20240302366A1 (en) | Immunological assay method | |
| JP4657328B2 (ja) | 免疫反応干渉物質の除去方法 | |
| Krishnan et al. | Behaviour of non-donor specific antibodies during rapid re-synthesis of donor specific HLA antibodies after antibody incompatible renal transplantation | |
| JPWO2022118947A5 (https=) | ||
| JP5714791B2 (ja) | 非特異反応抑制剤 | |
| JP2678273B2 (ja) | 免疫定量法 | |
| US20230375544A1 (en) | Methods for Determining a Level of Cell-Bound Complement Activation Product | |
| FI904304A0 (fi) | Foerfarande foer paovisande av analyter. | |
| Blumberg et al. | Hepatitis B testing reagent and method |